• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特比萘芬和伊曲康唑对马尔尼菲青霉的体外比较。

In vitro comparison of terbinafine and itraconazole against Penicillium marneffei.

作者信息

McGinnis M R, Nordoff N G, Ryder N S, Nunn G B

机构信息

Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555-0609, USA.

出版信息

Antimicrob Agents Chemother. 2000 May;44(5):1407-8. doi: 10.1128/AAC.44.5.1407-1408.2000.

DOI:10.1128/AAC.44.5.1407-1408.2000
PMID:10770792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC89885/
Abstract

We evaluated terbinafine and itraconazole against 30 isolates of Penicillium marneffei using a modification of the National Committee for Clinical Laboratory Standards broth macrodilution MIC testing protocol for yeasts. The minimal fungicidal concentration (MFC) was determined by plating 100 microl from each MIC drug dilution having no growth onto Sabouraud glucose agar incubated at 30 degrees C. The MFC was the dilution at which growth was absent at 72 h of incubation. The MICs, in micrograms per milliliter, were as follows: terbinafine, 0.03 to 1.0 (geometric mean titer, 0.09); itraconazole, 0.03 to 0.5 (geometric mean titer, 0.04). The MFCs, in micrograms per milliliter, were as follows: terbinafine, 0.03 to 8 (geometric mean titer, 2.60); itraconazole, 0.03 to 8 (geometric mean titer, 2. 45). Primary fungicidal activity (MFC within 2 dilutions of MIC) was observed with terbinafine in eight isolates and with itraconazole in four isolates. The data indicate that terbinafine is active against P. marneffei in vitro and may have a previously unrealized role in the management of infections caused by this fungus.

摘要

我们采用针对酵母菌的美国国家临床实验室标准委员会肉汤宏稀释法 MIC 检测方案的改良方法,评估了特比萘芬和伊曲康唑对 30 株马尔尼菲青霉菌株的抗菌活性。通过将每份无生长的 MIC 药物稀释液中的 100 微升接种到 30℃培养的沙氏葡萄糖琼脂平板上,来确定最低杀菌浓度(MFC)。MFC 是在培养 72 小时后无生长的稀释度。MIC 以微克/毫升计,结果如下:特比萘芬,0.03 至 1.0(几何平均滴度,0.09);伊曲康唑,0.03 至 0.5(几何平均滴度,0.04)。MFC 以微克/毫升计,结果如下:特比萘芬,0.03 至 8(几何平均滴度,2.60);伊曲康唑,0.03 至 8(几何平均滴度,2.45)。在 8 株菌株中观察到特比萘芬具有主要杀菌活性(MFC 在 MIC 的 2 个稀释度范围内),在 4 株菌株中观察到伊曲康唑具有主要杀菌活性。数据表明,特比萘芬在体外对马尔尼菲青霉具有活性,在该真菌引起的感染治疗中可能具有此前未被认识到的作用。

相似文献

1
In vitro comparison of terbinafine and itraconazole against Penicillium marneffei.特比萘芬和伊曲康唑对马尔尼菲青霉的体外比较。
Antimicrob Agents Chemother. 2000 May;44(5):1407-8. doi: 10.1128/AAC.44.5.1407-1408.2000.
2
In vitro antifungal drug susceptibilities of Penicillium marneffei from China.中国马尔尼菲青霉的体外抗真菌药敏试验。
J Infect Chemother. 2013 Aug;19(4):776-8. doi: 10.1007/s10156-012-0511-7. Epub 2012 Oct 28.
3
Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.特比萘芬和伊曲康唑的杀菌与抑菌活性:体外比较
J Am Acad Dermatol. 1998 May;38(5 Pt 3):S37-41. doi: 10.1016/s0190-9622(98)70482-7.
4
In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis.特比萘芬和伊曲康唑对巴西副球孢子菌活性的体外比较。
J Clin Microbiol. 2002 Aug;40(8):2828-31. doi: 10.1128/JCM.40.8.2828-2831.2002.
5
In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.环吡酮、特比萘芬、酮康唑和伊曲康唑对皮肤癣菌和非皮肤癣菌的体外药敏试验以及联合抗真菌活性的体外评估。
Br J Dermatol. 2003 Aug;149(2):296-305. doi: 10.1046/j.1365-2133.2003.05418.x.
6
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.特比萘芬与两性霉素B、氟康唑及伊曲康唑对白色念珠菌临床分离株的体外相互作用
J Antimicrob Chemother. 1998 Jan;41(1):59-65. doi: 10.1093/jac/41.1.59.
7
[In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].酮康唑、伊曲康唑和特比萘芬对从新生儿分离出的马拉色菌菌株的体外活性
Mikrobiyol Bul. 2005 Jul;39(3):301-8.
8
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.特比萘芬与三唑类药物或两性霉素B对曲霉菌的协同相互作用。
Med Mycol. 2001 Feb;39(1):91-5. doi: 10.1080/mmy.39.1.91.95.
9
In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi.特比萘芬和伊曲康唑对暗色真菌的体外评价。
Med Mycol. 1998 Aug;36(4):243-6.
10
Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.特比萘芬对甲癣致病皮肤癣菌和短帚霉的药敏模式。
Int J Antimicrob Agents. 2008 Jun;31(6):540-3. doi: 10.1016/j.ijantimicag.2008.01.023. Epub 2008 Mar 25.

引用本文的文献

1
Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffei.显色法测定二相性真菌马尔尼菲篮状菌抗真菌药物敏感性的方法的建立和验证。
Med Mycol. 2023 Nov 6;61(11). doi: 10.1093/mmy/myad111.
2
Comparison of in vitro Susceptibilities of in Mold and Yeast Forms in Malaysia.马来西亚霉菌和酵母形态体外药敏性比较。
Infect Drug Resist. 2023 Mar 22;16:1629-1635. doi: 10.2147/IDR.S398743. eCollection 2023.
3
Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and Anidulafungin.泊沙康唑通过肉汤微量稀释法和Etest法对马尔尼菲篮状菌的活性及其与伊曲康唑、伏立康唑和阿尼芬净的比较
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01480-16. Print 2017 Mar.
4
Melanization and morphological effects on antifungal susceptibility of Penicillium marneffei.马尔尼菲青霉的黑化及其对抗真菌药敏性的形态学影响
Antonie Van Leeuwenhoek. 2014 Nov;106(5):1011-20. doi: 10.1007/s10482-014-0270-9. Epub 2014 Sep 17.
5
In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.柬埔寨马尔尼菲青霉菌株丝状和酵母形式的体外抗真菌药物敏感性
J Clin Microbiol. 2006 Nov;44(11):4208-10. doi: 10.1128/JCM.00902-06. Epub 2006 Sep 13.
6
In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.特比萘芬对曲霉菌属的体外活性与伊曲康唑和两性霉素B的比较。
Antimicrob Agents Chemother. 2001 Jun;45(6):1882-5. doi: 10.1128/AAC.45.6.1882-1885.2001.

本文引用的文献

1
In vitro evaluation of terbinafine and itraconazole against dematiaceous fungi.特比萘芬和伊曲康唑对暗色真菌的体外评价。
Med Mycol. 1998 Aug;36(4):243-6.
2
In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications.丝状子囊菌对伏立康唑、伊曲康唑和两性霉素B敏感性的体外测试,并考虑系统发育影响。
J Clin Microbiol. 1998 Aug;36(8):2353-5. doi: 10.1128/JCM.36.8.2353-2355.1998.
3
Pathology of Penicillium marneffei. An emerging acquired immunodeficiency syndrome-related pathogen.马尔尼菲青霉的病理学。一种新出现的与获得性免疫缺陷综合征相关的病原体。
Arch Pathol Lab Med. 1997 Aug;121(8):798-804.
4
In vitro evaluation of voriconazole against some clinically important fungi.伏立康唑对某些临床重要真菌的体外评价。
Antimicrob Agents Chemother. 1997 Aug;41(8):1832-4. doi: 10.1128/AAC.41.8.1832.
5
In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.新型三唑类药物D0870对马尔尼菲青霉菌的体外抗真菌活性与两性霉素B、氟康唑、伊曲康唑、咪康唑和氟胞嘧啶的比较。
Mycoses. 1996 Nov-Dec;39(11-12):453-6. doi: 10.1111/j.1439-0507.1996.tb00096.x.
6
Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.人类免疫缺陷病毒感染患者播散性马尔尼菲青霉感染对抗真菌治疗的反应及临床标本分离株的体外药敏情况
Antimicrob Agents Chemother. 1993 Nov;37(11):2407-11. doi: 10.1128/AAC.37.11.2407.
7
Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei.人类致病真菌马尔尼菲青霉的系统发育及聚合酶链反应鉴定
J Clin Microbiol. 1995 Jan;33(1):85-9. doi: 10.1128/jcm.33.1.85-89.1995.
8
In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.马尔尼菲青霉和隐秘腐霉对多种抗真菌剂的体外敏感性
Eur J Epidemiol. 1992 May;8(3):427-32. doi: 10.1007/BF00158578.